Apollon Formularies PLC - London-based medical cannabis pharmaceutical firm - Expands production facility in Negril, Jamaica through the purchase of a new distiller, which will lead to the generation of additional revenue.
There is also the installation of a sonicator allowing for the production of nanoparticle medicines and water-oil emulsions, and the acquisition of an industrial freeze drier, allowing for more flexibility to store freeze dried biomass.
"We are delighted to have expanded our state-of-the-art production facility in Negril. Our new extraction facility significantly increases our production capabilities whilst also deepening our future product offering and improving product storage. Upgrading our facility means that we have more than enough production capability to operationally support Apollon's activities as we continue our strategy to expand our local and, eventually, global footprint," says Chief Operating Officer Stephen Barnhill Jr.
Current stock price: 2.7 pence
Year-to-date change: down 58%
By Dayo Laniyan; dayolaniyan@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.